RAD - Rite Aid Corporation

NYSE - NYSE Delayed Price. Currency in USD
1.58
-0.02 (-1.25%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close1.60
Open1.61
Bid0.00 x 0
Ask0.00 x 0
Day's Range1.57 - 1.63
52 Week Range1.38 - 4.29
Volume7,406,374
Avg. Volume23,006,103
Market Cap1.678B
Beta1.90
PE Ratio (TTM)10.68
EPS (TTM)0.15
Earnings DateSep 20, 2017 - Sep 25, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date1999-10-14
1y Target Est2.04
Trade prices are not sourced from all markets
  • MARKETS: Earnings season could ramp the S&P 500 4.5% to 2800
    Yahoo Finance Video9 days ago

    MARKETS: Earnings season could ramp the S&P 500 4.5% to 2800

    Yahoo Finance's Jared Blikre joins Seana Smith live from the New York Stock Exchange to discus the latest market moves.

  • Politics of pot: How Boehner’s attitude reversal is changing the weed industry
    Yahoo Finance Video9 days ago

    Politics of pot: How Boehner’s attitude reversal is changing the weed industry

    Former House Speaker John Boehner has signed on as an advisor to a cannabis company. Yahoo Finance’s Alexis Christoforous, Acreage Holdings CEO Kevin Murphy, and former Massachusetts Governor William Weld discuss how the industry is changing with increased support from government leaders.

  • Rite Aid misses, UK says Disney must bid for Sky, Tesla’s Model Y to reportedly start production in 2019
    Yahoo Finance Video9 days ago

    Rite Aid misses, UK says Disney must bid for Sky, Tesla’s Model Y to reportedly start production in 2019

    Rite Aid, Disney, Fox, Tesla and Apple are the companies to watch.

  • Naloxone available at Rite-Aid without prescription
    American City Business Journals17 hours ago

    Naloxone available at Rite-Aid without prescription

    Drug that reverses opioid overdose will be available in 19 states, the retailer announces.

  • Business Wire2 days ago

    Rite Aid Commences Offer to Purchase Certain of its Outstanding Series of Notes

    Rite Aid Corporation today announced that it has commenced an offer to purchase for cash up to $700,000,000 of certain of its outstanding indebtedness, consisting of its 6.75% Senior Notes due 2021 and 6.125% Senior Notes due 2023 , with a portion of the net cash proceeds received from its previously announced sale to Walgreens Boots Alliance, Inc.

  • Business Wire2 days ago

    Naloxone Available at Rite Aid Pharmacies in 19 States

    Rite Aid Corporation (RAD) announced today that naloxone, a medication that can be used to reverse the effects of an opioid overdose, is available at each of the more than 2,500 Rite Aid pharmacies in the United States and can be dispensed without a prescription, subject to state regulations. “The opioid epidemic has reached epic proportions and it is an issue that demands not only our attention but also our continued action to help reduce the rise in opioid deaths,” said Jocelyn Konrad, Rite Aid executive vice president of pharmacy. “For the past two years, we’ve worked with state and federal lawmakers to increase access to this life-saving medication.

  • Moody's3 days ago

    Albertsons Companies, LLC -- Moody's assigns B1 CFR to Albertsons Companies, Inc.; outlook negative

    Moody's Investors Service, ("Moody's") today assigned a B1 Corporate Family Rating and B1-PD probability of default rating to Albertsons Companies, Inc. ("Albertsons"). Moody's also ...

  • A Look at Rite Aid’s Fiscal 2019 Guidance
    Market Realist3 days ago

    A Look at Rite Aid’s Fiscal 2019 Guidance

    Rite Aid’s (RAD) management provided guidance for fiscal 2019 in its fiscal 4Q18 report. Management believes the company will benefit from generic drug purchasing efficiencies, a more stable reimbursement rate environment, Walgreens’s deal-related TSA (Transportation Security Administration) fees, and the company’s ongoing initiatives in fiscal 2019.

  • What Drove Down Rite Aid’s Fiscal 4Q18 Sales?
    Market Realist4 days ago

    What Drove Down Rite Aid’s Fiscal 4Q18 Sales?

    As we saw in the previous part of this series, Rite Aid (RAD) reported an 8.6% YoY (year-over-year) decline in its fiscal 4Q18 revenues from continuing operations to $5.4 billion. Its Retail Pharmacy segment, which includes prescription drugs, health and beauty products, and personal care items, saw its revenue fall 10.1% to $4 billion. Same-store sales from continuing operations fell 1.7% YoY during the quarter, driven by a 2.3% decline in pharmacy sales and a 0.6% fall in front-end sales.

  • Investopedia4 days ago

    Pharmacy Stocks Rise on News Amazon is Backing Off

    Pharmacy stocks got a lift in trading Monday after CNBC reported Amazon is backing off of selling drugs to hospitals.

  • Rite Aid’s Top Line Fell for 4th Straight Quarter in Fiscal 4Q18
    Market Realist4 days ago

    Rite Aid’s Top Line Fell for 4th Straight Quarter in Fiscal 4Q18

    Rite Aid (RAD) reported its fiscal 4Q18 results after the market closed on Thursday, April 12, 2018. Its top line fell 8.6% YoY (year-over-year) to $5.4 billion, missing the average consensus expectation by $180 million.

  • Why Did CVS Move Higher on April 16?
    Market Realist4 days ago

    Why Did CVS Move Higher on April 16?

    CVS (CVS), which is an American retail pharmacy and healthcare company, was the S&P 500’s second-highest performer on April 16. After gaining for three consecutive trading days, CVS opened higher on Monday and surged to four-week high price levels.

  • Rite Aid’s Fiscal 4Q18 Results: In-Line Earnings, Revenue Miss
    Market Realist4 days ago

    Rite Aid’s Fiscal 4Q18 Results: In-Line Earnings, Revenue Miss

    On Thursday, April 12, 2018, Rite Aid (RAD) reported its results for fiscal 4Q18 and fiscal 2018. The results relate to the three-month and 12-month period that ended March 3, 2018.

  • ACCESSWIRE4 days ago

    Today’s Research Reports on Stocks to Watch: Walgreens Boots Alliance and Rite Aid

    NEW YORK, NY / ACCESSWIRE / April 17, 2018 / Shares of Walgreens and Rite Aid saw gains on Monday after reports emerged that Amazon has shelved its plans to sell prescription drugs to doctors and hospitals. ...

  • GlobeNewswire5 days ago

    Report: Developing Opportunities within Amicus Therapeutics, Rite Aid, Navient, ProPetro Holding, Pfizer, and Sysco — Future Expectations, Projections Moving into 2018

    NEW YORK, April 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...

  • Forbes6 days ago

    Even As Amazon Lurks, Drugstores Look To Bricks And Mortar

    Despite the threat of Amazon entering the pharmacy business, Walgreens, CVS and Rite Aid see corner locations and bricks and mortar expansions as a consumer's entry point for health access.

  • Rite Aid (RAD) Q4 2018 Earnings Conference Call Transcript
    Motley Fool8 days ago

    Rite Aid (RAD) Q4 2018 Earnings Conference Call Transcript

    RAD earnings call for the period ending March 3, 2018.

  • Investopedia8 days ago

    Why Rite Aid Shareholders Oppose Albertsons Merger

    Critics indicate that the pharmacy chain could do a better job revamping its stores on its own.

  • Rite Aid (RAD) Reports Narrower-Than-Estimated Loss in Q4
    Zacks8 days ago

    Rite Aid (RAD) Reports Narrower-Than-Estimated Loss in Q4

    Rite Aid (RAD) reports better-than-expected bottom-line results for fourth-quarter fiscal 2018, while sales disappoint. Improvement in reimbursement rates aid results.

  • Forbes8 days ago

    Rite Aid Sees 'Mid-Sized Market' Future For Its PBM

    Rite Aid sees a future to grow its EnvisionRx pharmacy benefit manager selling services to “mid-sized” companies and employer clients.

  • The Wall Street Journal8 days ago

    Rite Aid Shareholders Sour on Albertsons Deal

    Some Rite Aid Corp. shareholders plan to oppose a merger with grocer Albertsons Cos. that they believe undervalues the struggling pharmacy chain. Rite Aid’s shares have fallen about 20% since the companies said they would merge on Feb. 20, a sign of deepening investor disapproval. Albertsons is closely held.

  • Rite Aid Corporation Earnings: Q4 Highlights
    InvestorPlace9 days ago

    Rite Aid Corporation Earnings: Q4 Highlights

    Here are a few highlights from Rite Aid Corporation’s most recent earnings report. The company reported losses per share of one penny for its fiscal fourth quarter of 2018. This is a drop from its earnings per share of 2 cents from the same time last year.

  • Forbes9 days ago

    Rite Aid To Escalate 'Wellness' Focus For Stores In Albertsons Deal

    Rite Aid will escalate the conversion of its pharmacies to "wellness stores" and will also look at new freestanding stores once its deal with grocer Albertsons closes later this year.

  • Reuters9 days ago

    Drug retailer Rite Aid's upbeat forecast lifts shares

    Drug retailer Rite Aid Corp on Thursday forecast a full-year profit largely above estimates as it expects reimbursement rates to rise this year and its deal with Walgreens to help it secure better generic drug prices. Rite Aid sold half of its stores to Walgreens Boots Alliance Inc last year after Walgreens' bid to buy the whole company collapsed due to antitrust concerns. The much smaller Rite Aid then agreed to be bought by U.S. grocer Albertsons Cos Inc, hoping to still remain a formidable player in the sector.

  • See what the IHS Markit Score report has to say about Rite Aid Corp.
    Markit9 days ago

    See what the IHS Markit Score report has to say about Rite Aid Corp.

    This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on February 21. Index (PMI) data, output in the Consumer Services sector is rising.